Subbu Nambi Analyst PerformanceManaging Director & Equity Research Analyst at GuggenheimSubbu Nambi is a stock analyst at Guggenheim focused in the medical sector, covering 22 publicly traded companies. Over the past year, Subbu Nambi has issued 47 stock ratings, including buy and hold recommendations. While full access to Subbu Nambi's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Subbu Nambi's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings57 Last 1 YearsBuy Recommendations94.74% 54 Buy RatingsCompanies Covered22 Unique Companies Ratings Distribution57RatingsDistribution of strong buy, buy, hold, and sell ratings by Subbu Nambi.RatingPercentageCount Strong Buy0.0%0 ratings Buy94.7%54 ratings Hold5.3%3 ratings Sell0.0%0 ratingsOut of 57 total stock ratings issued by Subbu Nambi at Guggenheim, the majority (94.7%) have been Buy recommendations, followed by 5.3% Hold.Best & Worst CallsBest Call0000.0%GHJan 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call00.0%ILMNFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ86.4% of companies on NASDAQ19 companiesNYSE13.6% of companies on NYSE3 companiesSubbu Nambi, an analyst at Guggenheim, currently covers 22 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical19 companies86.4%Services1 company4.5%Transportation1 company4.5%Computer and Technology1 company4.5%Subbu Nambi of Guggenheim specializes in stock coverage within the Medical sector, with additional focus on Services and Transportation companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE9 companies40.9%MEDICAL SERVICES4 companies18.2%MEDICAL INFO SYS2 companies9.1%MED INSTRUMENTS2 companies9.1%SERVICES – HEALTH1 company4.5%TRANS - SERVICES1 company4.5%INSTRU - SCIENTFC1 company4.5%MED - GENERIC DRG1 company4.5%MED PRODUCTS1 company4.5% About Subbu NambiDr. Nambi is a Managing Director and Equity Research Analyst covering the Diagnostics & Life Sciences Tools sector. Before joining Guggenheim, she was a Research Director at General Atlantic, a private equity firm, where she focused on both public and private investment in the firm’s Life Sciences sector. Prior to that, Dr. Nambi was a Vice President on the Life Science Tools and Diagnostics team at Cowen. She also covered the Biotechnology sector at Cowen, where her focus was SMID cap biotech companies. Dr. Nambi holds a Ph.D. from the Indian Institute of Science.Follow on LinkedIn Subbu Nambi's Ratings History at Guggenheim Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsBLLNBilliontoone5/13/2026Boost Price Target$94.23$120.00Buy$0.0000.00% ROIADPTAdaptive Biotechnologies5/6/2026Reiterated Rating$13.97$21.00Buy$0.0000.00% ROITWSTTwist Bioscience5/5/2026Boost Price Target$56.19$60.00Buy$0.0000.00% ROICYRXCryoPort5/5/2026Boost Price Target$10.21$12.00Buy$0.0000.00% ROIWGSGeneDx5/5/2026Lower Price Target$67.93$70.00Buy$0.0000.00% ROIDHRDanaher4/22/2026Lower Price Target$194.52$235.00Buy$0.0000.00% ROIWGSGeneDx3/30/2026Lower Price Target$60.13$100.00Buy$0.0000.00% ROIBLLNBilliontoone3/30/2026Lower Price Target$71.99$100.00Buy$0.0000.00% ROIGRALGRAIL3/30/2026Lower Price Target$47.94$75.00Buy$0.0000.00% ROITEMTempus AI3/30/2026Lower Price Target$42.45$60.00Buy$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. TWSTTwist Bioscience3/30/2026Boost Price Target$44.45$55.00Buy$0.0000.00% ROIVCYTVeracyte3/30/2026Lower Price Target$30.17$45.00Buy$0.0000.00% ROIBRKRBruker3/30/2026Lower Price Target$34.59$50.00Buy$0.0000.00% ROIBLLNBilliontoone3/5/2026Reiterated Rating$80.83$120.00Buy$0.0000.00% ROINAUTNautilus Biotechnology2/27/2026Boost Price Target$2.43$4.00Buy$0.0000.00% ROIWATWaters2/10/2026Reiterated Rating$332.08$440.00Buy$0.0000.00% ROISOPHSOPHiA GENETICS1/26/2026Boost Price Target$5.41$7.00Buy$0.0000.00% ROIPSNLPersonalis1/26/2026Boost Price Target$10.29$13.00Buy$0.0000.00% ROIILMNIllumina1/26/2026Boost Price Target$149.15$170.00Buy$0.0000.00% ROIGRALGRAIL1/26/2026Boost Price Target$108.74$130.00Buy$0.0000.00% ROIGHGuardant Health1/26/2026Boost Price Target$117.21$135.00Buy$0.0000.00% ROICSTLCastle Biosciences1/26/2026Boost Price Target$43.26$47.00Buy$0.0000.00% ROIBRKRBruker1/26/2026Boost Price Target$49.14$58.00Buy$0.0000.00% ROIADPTAdaptive Biotechnologies1/26/2026Boost Price Target$18.96$21.00Buy$0.0000.00% ROINEOGNeogen1/9/2026Reiterated Rating$9.69$12.00Buy$0.0000.00% ROIWATWaters1/6/2026Initiated Coverage$394.99$440.00Buy$0.0000.00% ROIWATWaters1/6/2026Initiated Coverage$400.31$440.00Buy$0.0000.00% ROIVCYTVeracyte1/5/2026Boost Price Target$43.29$50.00Buy$0.0000.00% ROINTRANatera1/5/2026Boost Price Target$231.01$270.00Buy$0.0000.00% ROIILMNIllumina1/5/2026Boost Price Target$138.08$144.00Buy$0.0000.00% ROIGHGuardant Health1/5/2026Boost Price Target$98.12$115.00Buy$0.0000.00% ROICSTLCastle Biosciences1/5/2026Boost Price Target$38.00$43.00Buy$0.0000.00% ROIBRKRBruker1/5/2026Boost Price Target$49.87$53.00Buy$0.0000.00% ROIDHRDanaher1/2/2026Boost Price Target$230.42$275.00Buy$0.0000.00% ROIEXASExact Sciences11/20/2025Downgrade$101.14Neutral$0.0000.00% ROIGRALGRAIL11/12/2025Upgrade$83.39$100.00Buy$0.0000.00% ROIPSNLPersonalis11/11/2025Boost Price Target$8.63$12.00Buy$0.0000.00% ROIVCYTVeracyte11/5/2025Boost Price Target$44.20$45.00Buy$0.0000.00% ROIEXASExact Sciences11/4/2025Boost Price Target$72.23$75.00Buy$0.0000.00% ROIWGSGeneDx10/29/2025Reiterated Rating$137.47$170.00Buy$0.0000.00% ROIThe REAL Reason Trump is Invading Iran (Ad)For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.Click here to find out what it is.RVTYRevvity10/15/2025Initiated Coverage$92.12Neutral$0.0000.00% ROIADPTAdaptive Biotechnologies9/30/2025Initiated Coverage$13.46$20.00Buy$0.0000.00% ROITEMTempus AI9/26/2025Boost Price Target$77.33$95.00Buy$0.0000.00% ROIGHGuardant Health9/25/2025Boost Price Target$57.67$67.00Buy$0.0000.00% ROIDHRDanaher7/23/2025Reiterated Rating$190.04$250.00Buy$0.0000.00% ROITEMTempus AI6/30/2025Boost Price Target$66.52$75.00Buy$0.0000.00% ROINEOGNeogen6/30/2025Lower Price Target$4.73$10.00Buy$0.0000.00% ROIILMNIllumina5/9/2025Lower Price Target$76.94$114.00Buy$000.0000.00% ROITWSTTwist Bioscience5/6/2025Reiterated Rating$35.21$50.00Buy$00.0000.00% ROIEXASExact Sciences4/11/2025Reiterated Rating$42.57$60.00Buy$0.0000.00% ROIMYGNMyriad Genetics4/9/2025Downgrade$7.73Neutral$0.0000.00% ROIEXASExact Sciences3/28/2025Set Price Target$44.99$60.00Buy$0.0000.00% ROICSTLCastle Biosciences3/28/2025Set Price Target$20.10$30.00Buy$00.0000.00% ROIGHGuardant Health2/24/2025Reiterated Rating$43.12$56.00Buy$00.0000.00% ROIILMNIllumina2/7/2025Lower Price Target$112.55$150.00Buy$000.0000.00% ROIGHGuardant Health1/22/2025Reiterated Rating$48.30Buy$000.0000.00% ROINTRANatera1/17/2025Boost Price Target$168.50$200.00Buy$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel NicolausRaymond James Financial Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
